SEC Seal
SEC Banner
Search the Next-Generation EDGAR System
Filing Detail
Form 10-Q - Quarterly report [Sections 13 or 15(d)]:
SEC Accession No. 0001047469-12-005755
Filing Date
2012-05-10
Accepted
2012-05-10 16:17:07
Documents
10
Period of Report
2012-03-31

Document Format Files

Seq Description Document Type Size
1 10-Q a2209148z10-q.htm 10-Q 671994
2 EX-31.1 a2209148zex-31_1.htm EX-31.1 7659
3 EX-31.2 a2209148zex-31_2.htm EX-31.2 7673
4 EX-32.1 a2209148zex-32_1.htm EX-32.1 4334
  Complete submission text file 0001047469-12-005755.txt   8326733

Data Files

Seq Description Document Type Size
5 EX-101.INS vrtx-20120331.xml EX-101.INS 778734
6 EX-101.SCH vrtx-20120331.xsd EX-101.SCH 138004
7 EX-101.CAL vrtx-20120331_cal.xml EX-101.CAL 85084
8 EX-101.LAB vrtx-20120331_lab.xml EX-101.LAB 2011756
9 EX-101.PRE vrtx-20120331_pre.xml EX-101.PRE 832994
10 EX-101.DEF vrtx-20120331_def.xml EX-101.DEF 506574
Mailing Address
Business Address 130 WAVERLY STREET CAMBRIDGE MA 02139-4242 6165776000
VERTEX PHARMACEUTICALS INC / MA (Filer) CIK: 0000875320 (see all company filings)

IRS No.: 043039129 | State of Incorp.: MA | Fiscal Year End: 1231
Type: 10-Q | Act: 34 | File No.: 000-19319 | Film No.: 12830528
SIC: 2834 Pharmaceutical Preparations